Dyne Therapeutics Stock Price on December 31, 2023
| DYN Stock | USD 30.61 0.52 1.67% |
Below is the normalized historical share price chart for Dyne Therapeutics extending back to September 17, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Dyne Therapeutics stands at 30.61, as last reported on the 29th of November, with the highest price reaching 31.29 and the lowest price hitting 29.73 during the day.
If you're considering investing in Dyne Stock, it is important to understand the factors that can impact its price. As of now, Dyne Stock is not too volatile. Dyne Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0016, which denotes the company had a 0.0016% return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Dyne Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Dyne Therapeutics' Standard Deviation of 5.39, mean deviation of 3.1, and Variance of 29.06 to check if the risk estimate we provide is consistent with the expected return of 0.0063%.
At this time, Dyne Therapeutics' Stock Based Compensation is very stable compared to the past year. As of the 29th of November 2024, Sale Purchase Of Stock is likely to grow to about 24.1 M, while Total Stockholder Equity is likely to drop about 86.7 M. . At this time, Dyne Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 29th of November 2024, Price To Book Ratio is likely to grow to 9.13, while Price To Sales Ratio is likely to drop 6.54. Dyne Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 17th of September 2020 | 200 Day MA 32.4934 | 50 Day MA 31.888 | Beta 1.095 |
Dyne |
Sharpe Ratio = 0.0016
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DYN |
Estimated Market Risk
| 3.88 actual daily | 34 66% of assets are more volatile |
Expected Return
| 0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Dyne Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dyne Therapeutics by adding Dyne Therapeutics to a well-diversified portfolio.
Price Book 4.4901 | Book Value 6.934 | Enterprise Value 2.5 B | Enterprise Value Ebitda (8.87) | Shares Float 74.8 M |
Related Headline
Theseus Pharmaceuticals Headline on 24th of July 2023
Theseus Pharmaceuticals Inc is lower by 3.62 percent Monday ... by news.google.com
Theseus Pharmaceuticals Inc is lower by 3.62 percent Monday In Premarket Trading InvestorsObserver
Dyne Therapeutics Valuation on December 31, 2023
It is possible to determine the worth of Dyne Therapeutics on a given historical date. On December 31, 2023 Dyne was worth 13.13 at the beginning of the trading date compared to the closed value of 13.3. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Dyne Therapeutics stock. Still, in general, we apply an absolute valuation method to find Dyne Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Dyne Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Dyne Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 13.60 | 13.80 | 13.02 | 13.16 | 884,110 | |
12/29/2023 | 13.13 | 13.74 | 12.86 | 13.30 | 722,711 |
| 13.02 | 13.82 | 12.57 | 13.06 | 1,169,318 |
| Backtest Dyne Therapeutics | | | Dyne Therapeutics History | | | Dyne Therapeutics Valuation | Previous | Next |
Dyne Therapeutics Trading Date Momentum on December 31, 2023
| On January 02 2024 Dyne Therapeutics was traded for 13.06 at the closing time. Highest Dyne Therapeutics's price during the trading hours was 13.82 and the lowest price during the day was 12.57 . The net volume was 1.2 M. The overall trading history on the 2nd of January contributed to the next trading period price depreciation. The overall trading delta to the next next day price was 1.80% . The overall trading delta to current price is 36.02% . |
Dyne Therapeutics Fundamentals Correlations and Trends
By evaluating Dyne Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Dyne Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Dyne financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Dyne Therapeutics Stock history
Dyne Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Dyne is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Dyne Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Dyne Therapeutics stock prices may prove useful in developing a viable investing in Dyne Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 59.7 M | 56.7 M | |
| Net Loss | -151.3 M | -143.7 M |
Dyne Therapeutics Quarterly Net Working Capital |
|
Dyne Therapeutics Stock Technical Analysis
Dyne Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Dyne Therapeutics Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Dyne Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Dyne Therapeutics November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Dyne Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dyne Therapeutics shares will generate the highest return on investment. By undertsting and applying Dyne Therapeutics stock market strength indicators, traders can identify Dyne Therapeutics entry and exit signals to maximize returns
Dyne Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Dyne Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Dyne Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Dyne to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.65) | |||
| Total Risk Alpha | (1.19) | |||
| Treynor Ratio | (0.16) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dyne Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne Therapeutics. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.58) | Return On Assets (0.40) | Return On Equity (0.69) |
The market value of Dyne Therapeutics is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dyne Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne Therapeutics' market value can be influenced by many factors that don't directly affect Dyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyne Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.